Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Consolidated Net Income (2020 - 2025)

Historic Consolidated Net Income for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to -$21.0 million.

  • Silence Therapeutics' Consolidated Net Income rose 4651.43% to -$21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$64.5 million, marking a year-over-year increase of 2320.54%. This contributed to the annual value of -$45.3 million for FY2024, which is 1562.71% up from last year.
  • According to the latest figures from Q3 2025, Silence Therapeutics' Consolidated Net Income is -$21.0 million, which was up 4651.43% from -$27.4 million recorded in Q2 2025.
  • In the past 5 years, Silence Therapeutics' Consolidated Net Income ranged from a high of $12.3 million in Q4 2024 and a low of -$39.2 million during Q3 2024
  • For the 5-year period, Silence Therapeutics' Consolidated Net Income averaged around -$16.5 million, with its median value being -$16.6 million (2021).
  • Its Consolidated Net Income has fluctuated over the past 5 years, first soared by 16622.85% in 2024, then tumbled by 56837.47% in 2025.
  • Over the past 5 years, Silence Therapeutics' Consolidated Net Income (Quarter) stood at -$15.1 million in 2021, then dropped by 16.64% to -$17.7 million in 2022, then decreased by 5.23% to -$18.6 million in 2023, then surged by 166.23% to $12.3 million in 2024, then tumbled by 270.36% to -$21.0 million in 2025.
  • Its Consolidated Net Income stands at -$21.0 million for Q3 2025, versus -$27.4 million for Q2 2025 and -$28.5 million for Q1 2025.